Zenvia Inc. (NASDAQ:ZENV - Get Free Report) saw a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 9,000 shares, a decline of 45.8% from the November 15th total of 16,600 shares. Based on an average daily volume of 50,000 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.1% of the shares of the company are short sold.
Zenvia Stock Performance
Shares of NASDAQ:ZENV traded down $0.03 on Thursday, reaching $1.64. The company's stock had a trading volume of 19,794 shares, compared to its average volume of 94,630. Zenvia has a 52-week low of $0.88 and a 52-week high of $3.88. The stock has a market capitalization of $68.68 million, a P/E ratio of -7.13 and a beta of 2.14. The stock's 50-day moving average is $1.42 and its two-hundred day moving average is $1.86. The company has a debt-to-equity ratio of 0.05, a current ratio of 0.50 and a quick ratio of 0.50.
About Zenvia
(
Get Free Report)
Zenvia Inc provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc is based in S?O PAULO.
Further Reading
Before you consider Zenvia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zenvia wasn't on the list.
While Zenvia currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.